P-ISSN 2587-2400 | E-ISSN 2587-196X
EJMO Sponsors
- Glead
- Pfizer
- Roche
- Amgen
- Astellas
- Bristol-Myers Squibb
- Arven
- Johnson Johnson
- Merck
- Novartis
- Omnigen
- Mustafa Nevzat
- TEVA
- Trpharm
In-vitro Evaluation of Effects of Mesenchymal Stem Cells on TLR3, TLR7/8 and TLR9-activated Natural Killer Cells